Cumberland Isotopes

Cumberland Isotopes is a medical isotope production company focused on the domestic supply of high-purity radionuclides for radiopharmaceutical applications. The company specializes in the production of no-carrier-added (n.c.a.) Lutetium-177 (Lu-177), a critical component for targeted radioligand therapies used in treating various cancers. Based in Oak Ridge, Tennessee, the company leverages local nuclear infrastructure to address global supply chain vulnerabilities in the oncology sector. Their mission is to ensure a stable and scalable supply of isotopes to support the development and commercialization of precision medicines. By providing high-quality isotopes, they enable pharmaceutical partners to advance next-generation cancer treatments.